Hospital
Peacehealth
Peacehealth was paid $1.06M by Medicaid between Jan 2018 and Dec 2024, across 63 billing codes. Its largest line is 99283, emergency room visit (moderate) — 31% of everything it billed.
33Billing provider infoPEACEHEALTH
FRIDAY HARBOR, WA 98250
FRIDAY HARBOR, WA 98250
33aNPI1487917233assigned 06/18/2012
33bProvider typeCritical Access Hospital
28Total paid$1.06M
24GClaims47,188
24DCodes billed63
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Washington
Rank by total paid#24 of 30
Median peer was paid$9.10M
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SEIRER, JEFFREY controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,738 | $126K | |
| 2019 | 5,214 | $108K | |
| 2020 | 5,018 | $109K | |
| 2021 | 6,901 | $174K | |
| 2022 | 9,298 | $222K | |
| 2023 | 9,217 | $197K | |
| 2024incomplete | 5,802 | $126K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 31% | 3,089 | 2,743 | $325K |
| 96361 | Intravenous infusion, hydration; each additional hour | 21% | 778 | 633 | $221K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 2,485 | 2,004 | $161K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.2% | 2,400 | 1,767 | $98K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.3% | 1,745 | 1,623 | $45K |
| 87631 | 2.7% | 445 | 418 | $29K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.6% | 452 | 306 | $27K |
| 80053 | Comprehensive metabolic panel | 1.9% | 4,475 | 3,762 | $21K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.9% | 186 | 172 | $20K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.7% | 3,167 | 1,898 | $18K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.2% | 171 | 167 | $13K |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 5,589 | 4,774 | $12K |
51 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 483 | $10K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,412 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,805 | $8K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,328 | $7K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 727 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,021 | $4K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 26 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 57 | $3K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 266 | $3K |
| 84484 | <1% | 923 | $3K | |
| 80061 | Lipid panel | <1% | 735 | $2K |
| 83605 | <1% | 305 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,547 | $2K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 14 | $1K |
| 84703 | <1% | 598 | $1K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 955 | $1K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 14 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 360 | $1K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 424 | $1K |
| 81001 | <1% | 1,570 | $1K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,059 | $879.02 |
| 80047 | <1% | 166 | $807.69 | |
| 86803 | <1% | 116 | $518.63 | |
| 83735 | <1% | 1,067 | $433.24 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 99 | $422.69 |
| 85027 | <1% | 141 | $404.24 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 12 | $304.20 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 120 | $159.35 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 12 | $152.10 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 135 | $83.95 |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 273 | $78.05 |
| 80305 | <1% | 163 | $75.83 | |
| 85014 | <1% | 157 | $75.73 | |
| 85610 | <1% | 115 | $74.72 | |
| 83690 | <1% | 281 | $60.51 | |
| 81003 | <1% | 98 | $52.85 | |
| 85652 | <1% | 52 | $51.43 | |
| 83550 | <1% | 13 | $47.47 | |
| 86140 | <1% | 14 | $41.97 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 17 | $37.20 |
| 83540 | <1% | 13 | $28.36 | |
| 90686 | <1% | 12 | $24.52 | |
| 87581 | <1% | 14 | $24.49 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 29 | $21.11 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 15 | $12.25 |
| A9270 | Non-covered item or service | 0% | 60 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 28 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 17 | $0.00 |
| 80306 | 0% | 15 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 227 | $0.00 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 96 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSEIRER, JEFFREY (SYS VP FIN INTEGRITY/CONTROLLER)
| Provider | Location | Paid |
|---|---|---|
| Peacehealth | Vancouver, WA | $81.65M |
| Peacehealth | Longview, WA | $48.29M |
| Peacehealth | Bellingham, WA | $47.27M |
| Peacehealth | Springfield, OR | $30.72M |
| Peacehealth | Eugene, OR | $13.35M |
| Peacehealth | Vancouver, WA | $2.56M |
| Peacehealth | Eugene, OR | $1.84M |
| Peacehealth | Vancouver, WA | $1.00M |
| Peacehealth | Vancouver, WA | $814K |
| Peacehealth | Springfield, OR | $395K |
| Peacehealth | Bellingham, WA | $77K |
| Peacehealth | Kelso, WA | $13K |
| Peacehealth | Ketchikan, AK | $9K |
| Peacehealth | Eugene, OR | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.